| Ident. | Authors (with country if any) | Title |
|---|
| 000216 |
Angela Scheuerle [États-Unis] ; Kathleen Wilson [États-Unis] | PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome |
| 000264 |
Tamar Shachar [Israël] ; Christophe Lo Bianco [Suisse] ; Alessandra Recchia [Suisse] ; Christoph Wiessner [Suisse] ; Annick Raas-Rothschild [Israël] ; Anthony H. Futerman [Israël] | Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond |
| 000307 |
Owen A. Ross [États-Unis] ; Karen N. Conneely [États-Unis] ; Tao Wang [États-Unis] ; Carles Vilarino-Guell [États-Unis, Canada] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Alex Rajput [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Ryan J. Uitti [États-Unis] ; Elan D. Louis [États-Unis] ; Lorraine N. Clark [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] ; Claudia M. Testa [États-Unis] | Genetic variants of α‐synuclein are not associated with essential tremor |
| 000317 |
Deborah A. Hall [États-Unis] ; Elizabeth Berry-Kravis [États-Unis] ; Wenting Zhang [États-Unis] ; Flora Tassone [États-Unis] ; Elaine Spector [États-Unis] ; Gary Zerbe [États-Unis] ; Paul J. Hagerman [États-Unis] ; Bichun Ouyang [États-Unis] ; Maureen A. Leehey [États-Unis] | FMR1 gray‐zone alleles: Association with Parkinson's disease in women? |
| 000332 |
Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France |
| 000350 |
Emma C. Schofield [Australie] ; John R. Hodges [Australie] ; Virginia Macdonald [Australie] ; Nicholas J. Cordato [Australie] ; Jillian J. Kril [Australie] ; Glenda M. Halliday [Australie] | Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy |
| 000367 |
Stanley Fahn [États-Unis] | Classification of movement disorders |
| 000407 |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 000596 |
Rebecca M. Wolf Gilbert [États-Unis] ; Stanley Fahn [États-Unis] ; Hiroshi Mitsumoto [États-Unis] ; Lewis P. Rowland [États-Unis] | Parkinsonism and motor neuron diseases: Twenty‐seven patients with diverse overlap syndromes |
| 000615 |
Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | Olfactory heterogeneity in LRRK2 related Parkinsonism |
| 000645 |
Francesco Roselli [Italie, Allemagne] ; Nicola M. Pisciotta [Italie] ; Michele Pennelli [Italie] ; Maria S. Aniello [Italie] ; Angelo Gigante [Italie] ; Maria F. De Caro [Italie] ; Ermanno Ferrannini [Italie] ; Bruno Tartaglione [Italie] ; Artor Niccoli-Asabella [Italie] ; Giovanni Defazio [Italie] ; Paolo Livrea [Italie] ; Giuseppe Rubini [Italie] | Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study |
| 000676 |
Jan Linder [Suède] ; Hans Stenlund [Suède] ; Lars Forsgren [Suède] | Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population‐based study |
| 000678 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders |
| 000745 |
Norbert Brüggemann [Allemagne] ; Susanne A. Schneider [Allemagne] ; Thurid Sander [Allemagne] ; Christine Klein [Allemagne] ; Johann Hagenah [Allemagne] | Distinct basal ganglia hyperechogenicity in idiopathic basal ganglia calcification |
| 000753 |
Anna Hussl [Autriche] ; Philipp Mahlknecht [Autriche] ; Christoph Scherfler [Autriche] ; Regina Esterhammer [Autriche] ; Michael Schocke [Autriche] ; Werner Poewe [Autriche] ; Klaus Seppi [Autriche] | Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain‐to‐pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy |
| 000755 |
Arjan W. Braam [Pays-Bas] ; Aartjan T. F. Beekman [Pays-Bas] ; Michael E. Dewey [Royaume-Uni] ; Philippe A. E. G. Delespaul [Pays-Bas] ; Manfred Fichter [Allemagne] ; Antonio Lobo [Espagne] ; Hallgrímur Magnússon [Islande] ; Karine Pérès [France] ; Friedel M. Reischies [Allemagne] ; Marc Roelands [Belgique] ; Pedro Saz [Espagne] ; Robert A. Schoevers [Pays-Bas] ; Ingmar Skoog [Suède] ; John R. M. Copeland [Royaume-Uni] | Depression and parkinsonism in older Europeans: results from the EURODEP concerted action |
| 000762 |
Mark R. Cookson [États-Unis] | DJ‐1, PINK1, and their effects on mitochondrial pathways |
| 000778 |
Christian Wider [États-Unis] ; Tatiana Foroud [États-Unis] ; Zbigniew K. Wszolek [États-Unis] | Clinical implications of gene discovery in Parkinson's disease and parkinsonism |
| 000779 |
Marta San Luciano [États-Unis] ; Richard B. Lipton [États-Unis] ; Cuiling Wang [États-Unis] ; Mindy Katz [États-Unis] ; Molly E. Zimmerman [États-Unis] ; Amy E. Sanders [États-Unis] ; Laurie J. Ozelius [États-Unis] ; Susan B. Bressman [États-Unis] ; Rachel Saunders-Pullman [États-Unis] | Clinical expression of LRRK2 G2019S mutations in the elderly |
| 000813 |
James H. Bower [États-Unis] ; Brandon R. Grossardt [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Robert C. Colligan [États-Unis] ; Yonas E. Geda [États-Unis] ; Terry M. Therneau [États-Unis] ; Walter A. Rocca [États-Unis] | Anxious personality predicts an increased risk of Parkinson's disease |
| 000844 |
Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni] | A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy |
| 000930 |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The use of a color coded probability scale to interpret smell tests in suspected parkinsonism |
| 000940 |
John Depaolo [États-Unis] ; Ozlem Goker-Alpan [États-Unis] ; Ted Samaddar [États-Unis] ; Grisel Lopez [États-Unis] ; Ellen Sidransky [États-Unis] | The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism |
| 000991 |
Anna Hotter [Autriche] ; Regina Esterhammer [Autriche] ; Michael F. H. Schocke [Autriche] ; Klaus Seppi [Autriche] | Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism |
| 000A00 |
Ichraf Kraoua [France] ; Jérôme Stirnemann [France] ; Maria João Ribeiro [France] ; Tiphaine Rouaud [France] ; Marc Verin [France] ; Agnès Annic [France] ; Christian Rose [France] ; Luc Defebvre [France] ; Liliane Réménieras [France] ; Michaël Schüpbach [France] ; Nadia Belmatoug [France] ; Marie Vidailhet [France] ; Frédéric Sedel [France] | Parkinsonism in Gaucher's disease type 1: Ten new cases and a review of the literature |
| 000B29 |
Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; John Hardy [Royaume-Uni] | Complicated recessive dystonia parkinsonism syndromes |
| 000D10 |
Asmar F. Al Hadithy [Pays-Bas] ; Bob Wilffert [Pays-Bas] ; Roy E. Stewart [Pays-Bas] ; Nicole M. Looman [Pays-Bas] ; Richard Bruggeman [Pays-Bas] ; Jacobus R. Brouwers [Pays-Bas] ; Glenn E. Matroos [Pays-Bas] ; Jim Van Os [Pays-Bas] ; Hans W. Hoek [Pays-Bas] ; Peter N. Van Harten [Pays-Bas] | Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African‐Caribbean inpatients: Differences in association with dopamine and serotonin receptors |
| 000D14 |
Hani T. S. Benamer [Royaume-Uni] ; Rajith De Silva [Royaume-Uni] ; Khurram A. Siddiqui ; Donald G. Grosset [Royaume-Uni] | Parkinson's disease in Arabs: A systematic review |
| 000D88 |
Aki S. Havulinna [Finlande] ; Pentti J. Tienari [Finlande] ; Reijo J. Marttila [Finlande] ; Kirsti K. Martikainen [Finlande] ; Johan G. Eriksson [Finlande] ; Olli Taskinen [Finlande] ; Elena Moltchanova [Finlande] ; Marjatta Karvonen [Finlande] | Geographical variation of medicated parkinsonism in Finland during 1995 to 2000 |
| 000F33 |
Charlene Hoffman Snyder [États-Unis] ; Charles H. Adler [États-Unis] | The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms |
| 001010 |
Elan D. Louis [États-Unis] ; David A. Bennett [États-Unis] | Mild Parkinsonian signs: An overview of an emerging concept |
| 001026 |
Osamu Yokota ; Kuniaki Tsuchiya ; Toshiki Uchihara ; Hiroshi Ujike ; Seishi Terada ; Mafuyu Takahashi ; Yuji Kimura ; Hideki Ishizu [Japon] ; Haruhiko Akiyama ; Shigetoshi Kuroda | Lewy body variant of Alzheimer’s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem |
| 001029 |
Radu Constantinescu [États-Unis] ; Irene Richard [États-Unis] ; Roger Kurlan [États-Unis] | Levodopa responsiveness in disorders with parkinsonism: A review of the literature |
| 001121 |
Masayuki Shintaku ; Kiyomitsu Oyanagi [Japon] ; Daita Kaneda | Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: Report of an autopsy case |
| 001127 |
Eduardo Tolosa [Espagne] ; Thierry Vander Borght [Belgique] ; Emilio Moreno [Espagne] | Accuracy of DaTSCAN (123I‐ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2‐Year follow‐up of an open‐label study |
| 001287 |
E. Sidransky [États-Unis] | Heterozygosity for a Mendelian disorder as a risk factor for complex disease |
| 001294 |
Elan D. Louis [États-Unis] ; Nicole Schupf [États-Unis] ; Karen Marder [États-Unis] ; Ming X. Tang [États-Unis] | Functional correlates of mild parkinsonian signs in the community‐dwelling elderly: Poor balance and inability to ambulate independently |
| 001335 |
Cynthia L. Leibson [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; James H. Bower [États-Unis] ; Jeanine E. Ransom [États-Unis] ; Peter C. O'Brien [États-Unis] ; Walter A. Rocca [États-Unis] | Comorbid conditions associated with Parkinson's disease: A population‐based study |
| 001410 |
Michel Goedert [Royaume-Uni] | Tau gene mutations and their effects |
| 001574 |
Fabio Guerini [Italie] ; Giovanni B. Frisoni [Italie] ; Catherine Bellwald [Italie] ; Roberta Rossi Psy [Italie] ; Giuseppe Bellelli [Italie] ; Marco Trabucchi [Italie] | Subcortical Vascular Lesions Predict Functional Recovery After Rehabilitation in Patients with L‐Dopa Refractory Parkinsonism |
| 001590 |
O. Goker-Alpan [États-Unis] ; R. Schiffmann [États-Unis] ; M E Lamarca [États-Unis] ; R L Nussbaum [États-Unis] ; A. Mcinerney-Leo [États-Unis] ; E. Sidransky [États-Unis] | Parkinsonism among Gaucher disease carriers |
| 001635 |
Elan D. Louis [États-Unis] ; Ming X. Tang [États-Unis] ; Richard Mayeux [États-Unis] | Factor structure of parkinsonian signs in the community‐dwelling elderly |
| 001683 |
David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Use of functional imaging in parkinsonism and dementia |
| 001703 |
Dominique Twelves [Royaume-Uni] ; Kate S. M. Perkins [Royaume-Uni] ; Carl Counsell [Royaume-Uni] | Systematic review of incidence studies of Parkinson's disease |
| 001723 |
Julián Benito-Le N [Espagne] ; Félix Bermejo-Pareja [Espagne] ; Javier Rodríguez [Espagne] ; José-Antonio Molina [Espagne] ; Rafael Gabriel [Espagne] ; José-Manuel Morales [Espagne] | Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain |
| 001734 |
Christopher Hawkes [Royaume-Uni] | Olfaction in neurodegenerative disorder |
| 001789 |
Stanley Fahn [États-Unis] | Description of Parkinson's Disease as a Clinical Syndrome |
| 001802 |
Brad A. Racette [États-Unis] ; Laura Good [États-Unis] ; Sandy Sagitto [États-Unis] ; Joel S. Perlmutter [États-Unis] | Botulinum toxin B reduces sialorrhea in parkinsonism |
| 001823 |
Sujana Reddy [États-Unis] ; Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Paul J. Feustel [États-Unis] | The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia |
| 001824 |
Werner Poewe [Autriche] ; G. Wenning [Autriche] | The differential diagnosis of Parkinson's disease |
| 001830 |
Andrew Feigin [États-Unis] ; Angelo Antonini [Italie] ; Masafumi Fukuda [États-Unis] ; Roberta De Notaris [Italie] ; Riccardo Benti [Italie] ; Gianni Pezzoli [Italie] ; Marc J. Mentis [États-Unis] ; James R. Moeller [États-Unis] ; David Eidelberg [États-Unis] | Tc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism |
| 001890 |
Maria Dolores Sevillano [Espagne] ; Jesús De Pedro-Cuesta [Espagne, Suède] ; Jacinto Duarte [Espagne] ; Luis Erik Clavería [Espagne] | Field validation of a method for population screening of parkinsonism |
| 001904 |
Y. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; J. Kim [Corée du Sud] ; C. Yoo [Corée du Sud] ; C. R. Lee [Corée du Sud] ; J. H. Lee [Corée du Sud] ; H. K. Kim [Corée du Sud] ; S. O. Yang [Corée du Sud] ; H. K. Chung [Corée du Sud] ; D. S. Lee [Corée du Sud] ; B. Jeon [Corée du Sud] | Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean? |
| 001A63 |
N. Tayebi ; M. Callahan ; V. Madike ; B. K. Stubblefield ; E. Orvisky ; D. Krasnewich ; J. J. Fillano ; E. Sidransky | Gaucher Disease and Parkinsonism: A Phenotypic and Genotypic Characterization |
| 001A89 |
S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France] | Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease |
| 001B76 |
Rolf Libelius [Suède] ; Folke Johansson [Suède] | Quantitative electromyography of the external anal sphincter in Parkinson's disease and multiple system atrophy |
| 001F16 |
A. Charlett [Royaume-Uni] ; R. J. Dobbs ; A. G. Purkiss ; D. J. Wrighe ; D. W. Peterson [Royaume-Uni] ; C. Weller ; S. M. Dobbs | Cortisol is higher in parkinsonism and associated with gait deficit |
| 002167 |
A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France] | Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? |
| 002689 |
J. De Pedro-Cuesta [Espagne] ; J. De Pedro-Cuesta [Espagne] | Parkinson's disease occurrence in Europe |
| 002690 |
J. De Pedro-Cuesta [Suède, Espagne] ; L. Stawiarz [Suède] | Parkinson's disease incidence: magnitude, comparability, time trends |
| 002981 |
Merle Ruberg [France] ; François Rieger [France] ; Albert Villageois [France] ; Anne Marie Bonnet ; Yves Agid [France] | Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease |
| 002A19 |
Charlotte Sachs [Suède] ; Bo Berglund [Suède] ; Lennart Kaijser [Suède] | Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa‐decarboxylase inhibition |
